{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:05:18Z","timestamp":1780567518384,"version":"3.54.1"},"reference-count":119,"publisher":"Elsevier","isbn-type":[{"value":"9780443295485","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.vh.2024.10.007","type":"book-chapter","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T16:01:24Z","timestamp":1731081684000},"page":"203-239","source":"Crossref","is-referenced-by-count":1,"title":["The thyroid endocrine axis in breast cancer pathophysiology and prognosis"],"prefix":"10.1016","member":"78","reference":[{"issue":"7","key":"10.1016\/bs.vh.2024.10.007_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/PAI.0b013e3182a20917","article-title":"The pattern of expression and role of triiodothyronine (T3) receptors and type I 5\u2032-deiodinase in breast carcinomas, benign breast diseases, lactational change, and normal breast epithelium","volume":"22","author":"Alyusuf","year":"2014","journal-title":"Applied Immunohistochemistry & Molecular Morphology: AIMM\/Official Publication of the Society for Applied Immunohistochemistry"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1590\/2359-3997000000191","article-title":"Is there an association between thyroid function abnormalities and breast cancer?","volume":"61","author":"Angelousi","year":"2017","journal-title":"Archives of Endocrinology and Metabolism"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.007_bib3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.007_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081186","article-title":"Genome-wide binding patterns of thyroid hormone receptor beta","volume":"9","author":"Ayers","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-020-05675-6","article-title":"Association between thyroid gland diseases and breast cancer: A case-control study","volume":"182","author":"Bach","year":"2020","journal-title":"Breast Cancer Research and Treatment"},{"issue":"10","key":"10.1016\/bs.vh.2024.10.007_bib6","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/ijc.25563","article-title":"Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study","volume":"128","author":"B\u00e4uerle","year":"2011","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"issue":"10","key":"10.1016\/bs.vh.2024.10.007_bib7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrendo.2017.47","article-title":"Central hypothyroidism \u2013 A neglected thyroid disorder","volume":"13","author":"Beck-Peccoz","year":"2017","journal-title":"Nature Reviews Endocrinology"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.007_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2967\/jnumed.107.045526","article-title":"Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET","volume":"49","author":"Beer","year":"2008","journal-title":"Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine"},{"issue":"7","key":"10.1016\/bs.vh.2024.10.007_bib9","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1210\/en.2005-0102","article-title":"Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis","volume":"146","author":"Bergh","year":"2005","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ecl.2018.10.008","article-title":"Thyroid hormone suppression therapy","volume":"48","author":"Biondi","year":"2019","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"issue":"12","key":"10.1016\/bs.vh.2024.10.007_bib11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/mc.23352","article-title":"Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells","volume":"60","author":"Bolf","year":"2021","journal-title":"Molecular Carcinogenesis"},{"issue":"9","key":"10.1016\/bs.vh.2024.10.007_bib12","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1172\/JCI60047","article-title":"Mechanisms of thyroid hormone action","volume":"122","author":"Brent","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"issue":"10","key":"10.1016\/bs.vh.2024.10.007_bib13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.30498","article-title":"A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes","volume":"123","author":"Buys","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/bs.vh.2024.10.007_bib14","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Network. (2012). Comprehensive molecular portraits of human breast tumours. Nature, 490(7418), 61\u201370. https:\/\/doi.org\/10.1038\/nature11412. PMID: 23000897; PMCID: PMC3465532.","DOI":"10.1038\/nature11412"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.007_bib15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/path.4490","article-title":"Tumour but not stromal expression of \u03b23 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer","volume":"235","author":"Carter","year":"2015","journal-title":"The Journal of Pathology"},{"issue":"8","key":"10.1016\/bs.vh.2024.10.007_bib16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.ejso.2017.05.012","article-title":"Thyroid hormone receptor alpha (TRa) tissue expression in ductal invasive breast cancer: A study combining quantitative immunohistochemistry with digital slide image analysis","volume":"43","author":"Charalampoudis","year":"2017","journal-title":"European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"key":"10.1016\/bs.vh.2024.10.007_bib17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3389\/fphar.2020.00640","article-title":"The thyrotropin-releasing hormone-degrading ectoenzyme, a therapeutic target?","volume":"11","author":"Charli","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.007_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/er.2009-0007","article-title":"Molecular aspects of thyroid hormone actions","volume":"31","author":"Cheng","year":"2010","journal-title":"Endocrine Reviews"},{"issue":"11","key":"10.1016\/bs.vh.2024.10.007_bib19","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib20","first-page":"211","article-title":"ITGAV targeting as a therapeutic approach for treatment of metastatic breast cancer","volume":"10","author":"Cheuk","year":"2020","journal-title":"American Journal of Cancer Research"},{"issue":"7","key":"10.1016\/bs.vh.2024.10.007_bib21","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3390\/cells9071730","article-title":"The molecular function and clinical role of thyroid stimulating hormone receptor in cancer cells","volume":"9","author":"Chu","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/bs.vh.2024.10.007_bib22","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1158\/1541-7786.MCR-11-0187","article-title":"Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via \u03b1v\u03b23 integrin","volume":"9","author":"Cohen","year":"2011","journal-title":"Molecular Cancer Research: MCR"},{"key":"10.1016\/bs.vh.2024.10.007_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/317398","article-title":"Thyroid hormone status interferes with estrogen target gene expression in breast cancer samples in menopausal women","volume":"2014","author":"Conde","year":"2014","journal-title":"ISRN Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/annonc\/mdj040","article-title":"Influence of thyroid hormone receptors on breast cancer cell proliferation","volume":"17","author":"Conde","year":"2006","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology\/ESMO"},{"issue":"9","key":"10.1016\/bs.vh.2024.10.007_bib25","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","article-title":"Associations between cancer predisposition testing panel genes and breast cancer","volume":"3","author":"Couch","year":"2017","journal-title":"JAMA Oncology"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.007_bib26","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/cncr.20881","article-title":"Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma","volume":"103","author":"Cristofanilli","year":"2005","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/thy.2006.0012","article-title":"Human breast cancer tissue expresses high level of type 1 5\u2032-deiodinase","volume":"17","author":"Debski","year":"2007","journal-title":"Thyroid: Official Journal of the American Thyroid Association"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1186\/s12967-023-04502-y","article-title":"Matched analysis of circulating selenium with the breast cancer selenotranscriptome: A multicentre prospective study","volume":"21","author":"Demircan","year":"2023","journal-title":"Journal of Translational Medicine"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.007_bib29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.onc.1205136","article-title":"Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells","volume":"21","author":"Dinda","year":"2002","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.007_bib30","first-page":"1713","article-title":"Thyroid function in breast cancer patients","volume":"30","author":"Ditsch","year":"2010","journal-title":"Anticancer Research"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.007_bib31","first-page":"227","article-title":"Thyroid hormone receptor (TR)alpha and TRbeta expression in breast cancer","volume":"28","author":"Ditsch","year":"2013","journal-title":"Histology and Histopathology"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.007_bib32","first-page":"1317","article-title":"High prevalence of hypothyroidism among patients with cutaneous melanoma","volume":"10","author":"Ellerhorst","year":"2003","journal-title":"Oncology Reports"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.007_bib33","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1677\/erc.1.01239","article-title":"Human melanoma cells express functional receptors for thyroid-stimulating hormone","volume":"13","author":"Ellerhorst","year":"2006","journal-title":"Endocrine-Related Cancer"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12672-016-0280-3","article-title":"Thyroid hormone controls breast cancer cell movement via integrin \u03b1V\/\u03b23\/SRC\/FAK\/PI3-kinases","volume":"8","author":"Flamini","year":"2017","journal-title":"Hormone Cancer"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.007_bib35","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1158\/1535-7163.MCT-20-0931","article-title":"Targeted therapy to \u03b23 integrin reduces chemoresistance in breast cancer bone metastases","volume":"20","author":"Fox","year":"2021","journal-title":"Molecular Cancer Therapeutics"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.007_bib36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/cts.13504","article-title":"Preclinical assessment of drug-drug interaction of fb-PMT, a novel anti-cancer thyrointegrin \u03b1v\u03b23 antagonist","volume":"16","author":"Fujioka","year":"2023","journal-title":"Clinical and Translational Science"},{"issue":"1-2","key":"10.1016\/bs.vh.2024.10.007_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0303-7207(03)00007-8","article-title":"Aceves C. 5\u2032Deiodinase in two breast cancer cell lines: Effect of triiodothyronine, isoproterenol and retinoids","volume":"201","author":"Garc\u00eda-Sol\u00eds","year":"2003","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"11","key":"10.1016\/bs.vh.2024.10.007_bib38","first-page":"2625","article-title":"Vascular integrin alpha(v)beta3: A new prognostic indicator in breast cancer","volume":"4","author":"Gasparini","year":"1998","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"11","key":"10.1016\/bs.vh.2024.10.007_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13260","article-title":"Thyroid hormones in diabetes, cancer, and aging","volume":"19","author":"Gauthier","year":"2020","journal-title":"Aging Cell"},{"issue":"21","key":"10.1016\/bs.vh.2024.10.007_bib40","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.4161\/cc.8.21.9963","article-title":"Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac)","volume":"8","author":"Glinskii","year":"2009","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"issue":"11","key":"10.1016\/bs.vh.2024.10.007_bib41","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3390\/cancers13112780","article-title":"Anti-cancer activities of thyrointegrin \u03b1v\u03b23 antagonist mono- and bis-triazole tetraiodothyroacetic acid conjugated via polyethylene glycols in glioblastoma","volume":"13","author":"Godugu","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70892-4","article-title":"Decreased expression of the thyroid hormone-inactivating enzyme type 3 deiodinase is associated with lower survival rates in breast cancer","volume":"10","author":"Goemann","year":"2020","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.007_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1515\/hmbci-2011-0130","article-title":"Expression of thyroid-stimulating hormone receptor, octamer-binding transcription factor 4, and intracisternal A particle-promoted polypeptide in human breast cancer tissues","volume":"9","author":"Govindaraj","year":"2012","journal-title":"Hormone Molecular Biology and Clinical Investigation"},{"issue":"30","key":"10.1016\/bs.vh.2024.10.007_bib44","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1038\/onc.2011.50","article-title":"Mutation of thyroid hormone receptor-\u03b2 in mice predisposes to the development of mammary tumors","volume":"30","author":"Guigon","year":"2011","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/bs.vh.2024.10.007_bib45","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1210\/en.2010-0475","article-title":"Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression","volume":"151","author":"Guigon","year":"2010","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.007_bib46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10549-015-3354-y","article-title":"Targeting thyroid hormone receptor beta in triple-negative breast cancer","volume":"150","author":"Gu","year":"2015","journal-title":"Breast Cancer Research and Treatment"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.007_bib47","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/IGC.0000000000000139","article-title":"Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas","volume":"24","author":"Gyftaki","year":"2014","journal-title":"International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society"},{"issue":"1-2","key":"10.1016\/bs.vh.2024.10.007_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsbmb.2007.12.008","article-title":"Effects of thyroid hormones on human breast cancer cell proliferation","volume":"109","author":"Hall","year":"2008","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.007_bib49","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.beem.2015.04.001","article-title":"Overlapping nongenomic and genomic actions of thyroid hormone and steroids","volume":"29","author":"Hammes","year":"2015","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2014-0308","article-title":"Medically induced euthyroid hypothyroxinemia may extend survival in compassionate need cancer patients: An observational study","volume":"20","author":"Hercbergs","year":"2015","journal-title":"The Oncologist"},{"key":"10.1016\/bs.vh.2024.10.007_bib51","article-title":"Thyroid) Hormonal regulation of breast cancer cells","volume":"13","author":"Hercbergs","year":"2023","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.007_bib52","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/cncr.24821","article-title":"A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma","volume":"116","author":"Hersey","year":"2010","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.007_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127072","article-title":"Thyroid hormone receptors predict prognosis in BRCA1 associated breast cancer in opposing ways","volume":"10","author":"Heublein","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.007_bib54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/cancers11020139","article-title":"Therapeutic potential of a novel \u03b1v\u03b2\u2083 antagonist to hamper the aggressiveness of mesenchymal triple negative breast cancer sub-type","volume":"11","author":"Hill","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.007_bib55","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10549-018-4844-5","article-title":"Thyroid hormone receptor beta-1 expression in early breast cancer: A validation study","volume":"171","author":"Jerzak","year":"2018","journal-title":"Breast Cancer Research and Treatment"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10549-014-3235-9","article-title":"Thyroid hormone receptor \u03b1 in breast cancer: Prognostic and therapeutic implications","volume":"149","author":"Jerzak","year":"2015","journal-title":"Breast Cancer Research and Treatment"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.007_bib57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4048\/jbc.2013.16.3.245","article-title":"The korean hereditary breast cancer study: Review and future perspectives","volume":"16","author":"Kang","year":"2013","journal-title":"Journal of Breast Cancer"},{"issue":"12","key":"10.1016\/bs.vh.2024.10.007_bib58","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1210\/jc.2016-2104","article-title":"Thyroid function and cancer risk: The Rotterdam study","volume":"101","author":"Khan","year":"2016","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"10.1016\/bs.vh.2024.10.007_bib59","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1016\/j.bbagen.2012.04.002","article-title":"Thyroid hormone receptors and cancer","volume":"1830","author":"Kim","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.vh.2024.10.007_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fendo.2019.00059","article-title":"Thyroid hormones and cancer: A comprehensive review of preclinical and clinical studies","volume":"10","author":"Krashin","year":"2019","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.007_bib61","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1074\/jbc.M806548200","article-title":"The frizzled-related sFRP2 gene is a target of thyroid hormone receptor alpha1 and activates beta-catenin signaling in mouse intestine","volume":"284","author":"Kress","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.007_bib62","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1053\/j.gastro.2010.01.041","article-title":"Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis","volume":"138","author":"Kress","year":"2010","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/bs.vh.2024.10.007_bib63","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"7","key":"10.1016\/bs.vh.2024.10.007_bib64","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.007_bib65","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5603\/EP.a2022.0020","article-title":"Free triiodothyronine and free thyroxine hormone levels in relation to breast cancer risk: A meta-analysis","volume":"73","author":"Lei","year":"2022","journal-title":"Endokrynologia Polska"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.007_bib66","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/07435800.2019.1600536","article-title":"Action of reverse T3 on cancer cells","volume":"44","author":"Lin","year":"2019","journal-title":"Endocrine Research"},{"issue":"20","key":"10.1016\/bs.vh.2024.10.007_bib67","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.3390\/ijms20204986","article-title":"Molecular functions of thyroid hormone signaling in regulation of cancer progression and anti-apoptosis","volume":"20","author":"Liu","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.007_bib68","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00418-017-1544-x","article-title":"Hypothyroidism reduces mammary tumor progression via \u0392-catenin-activated intrinsic apoptotic pathway in rats","volume":"147","author":"L\u00f3pez Fontana","year":"2017","journal-title":"Histochemistry and Cell Biology"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.007_bib69","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3892\/or.2013.2648","article-title":"RW. Experimental hypothyroidism increases apoptosis in dimethylbenzanthracene-induced mammary tumors","volume":"30","author":"L\u00f3pez-Fontana","year":"2013","journal-title":"Oncology Reports"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-018-0694-6","article-title":"14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin \u03b1v\u03b23 and activating FAK\/PI3K\/AKT signaling","volume":"37","author":"Luo","year":"2018","journal-title":"Journal of Experimental & Clinical Cancer Research: CR"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib71","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1186\/s12885-023-11049-0","article-title":"Association of reproductive risk factors and breast cancer molecular subtypes: A systematic review and meta-analysis","volume":"23","author":"Mao","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.vh.2024.10.007_bib72","series-title":"Endotext [Internet]","article-title":"Physiology of the hypothalamic-pituitary-thyroid axis. 2021 Apr 20","author":"Mariotti","year":"2000"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.007_bib73","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1158\/0008-5472.CAN-08-2198","article-title":"Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis","volume":"69","author":"Mart\u00ednez-Iglesias","year":"2009","journal-title":"Cancer Research"},{"issue":"48","key":"10.1016\/bs.vh.2024.10.007_bib74","doi-asserted-by":"crossref","first-page":"78971","DOI":"10.18632\/oncotarget.12978","article-title":"The nuclear corepressor 1 and the thyroid hormone receptor \u03b2 suppress breast tumor lymphangiogenesis","volume":"7","author":"Mart\u00ednez-Iglesias","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib75","doi-asserted-by":"crossref","first-page":"253","DOI":"10.21873\/anticanres.15480","article-title":"Thyroid hormones and morphological features of primary breast cancer","volume":"42","author":"Meirovitz","year":"2022","journal-title":"Anticancer Research"},{"issue":"11","key":"10.1016\/bs.vh.2024.10.007_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027547","article-title":"Crosstalk between integrin \u03b1v\u03b23 and estrogen receptor-\u03b1 is involved in thyroid hormone-induced proliferation in human lung carcinoma cells","volume":"6","author":"Meng","year":"2011","journal-title":"PLoS One"},{"issue":"1-5","key":"10.1016\/bs.vh.2024.10.007_bib77","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0960-0760(00)00151-5","article-title":"Hormonal regulation of tumor suppressor proteins in breast cancer cells","volume":"76","author":"Moudgil","year":"2001","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13402-011-0058-0","article-title":"BMP-7 inhibits TGF-\u03b2-induced invasion of breast cancer cells through inhibition of integrin \u03b2(3) expression","volume":"35","author":"Naber","year":"2012","journal-title":"Cellular oncology (Dordrecht)"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.007_bib79","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab016","article-title":"Deiodinases and cancer","volume":"162","author":"Nappi","year":"2021","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/bs.vh.2024.10.007_bib80","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.21873\/anticanres.14663","article-title":"Thyroid hormones, silencing mediator for retinoid and thyroid receptors and prognosis in primary breast cancer","volume":"40","author":"Nisman","year":"2020","journal-title":"Anticancer Research"},{"issue":"3-4","key":"10.1016\/bs.vh.2024.10.007_bib81","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0960-0760(96)00117-3","article-title":"Triiodothyronine mimics the effects of estrogen in breast cancer cell lines","volume":"59","author":"Nogueira","year":"1996","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.007_bib82","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/mc.22511","article-title":"Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor \u03b2","volume":"56","author":"Park","year":"2017","journal-title":"Molecular Carcinogenesis"},{"issue":"10","key":"10.1016\/bs.vh.2024.10.007_bib83","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1096\/fj.01-0911fje","article-title":"Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone","volume":"16","author":"P\u00e9cheur","year":"2002","journal-title":"The FASEB Journal"},{"issue":"8","key":"10.1016\/bs.vh.2024.10.007_bib84","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1128\/MCB.26.8.3204-3214.2006","article-title":"Thyroid hormone receptor alpha1 directly controls transcription of the beta-catenin gene in intestinal epithelial cells","volume":"26","author":"Plateroti","year":"2006","journal-title":"Molecular and Cellular Biology"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.007_bib85","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10549-014-2893-y","article-title":"Prevalence of breast cancer in thyroid diseases: Results of a cross-sectional study of 3,921 patients","volume":"144","author":"Prinzi","year":"2014","journal-title":"Breast Cancer Research and Treatment"},{"issue":"7","key":"10.1016\/bs.vh.2024.10.007_bib86","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.bmcl.2018.02.045","article-title":"Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer","volume":"28","author":"Rajabi","year":"2018","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.007_bib87","first-page":"761","article-title":"Profile of thyroid hormones in breast cancer patients","volume":"38","author":"Saraiva","year":"2005","journal-title":"Brazilian Journal of Medical and Biological Research = Revista Brasileira de Pesquisas Medicas e Biologicas\/Sociedade Brasileira de Biofisica \u2026 [et al.]"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.007_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020861","article-title":"3, 3\u20325 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements","volume":"6","author":"Sar","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.007_bib89","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1677\/JOE-07-0344","article-title":"Thyroid hormone stimulation of extracellular signal-regulated kinase and cell proliferation in human osteoblast-like cells is initiated at integrin alphaVbeta3","volume":"196","author":"Scarlett","year":"2008","journal-title":"The Journal of Endocrinology"},{"issue":"14","key":"10.1016\/bs.vh.2024.10.007_bib90","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.3390\/cancers15143610","article-title":"Cytoplasmic localization of thyroid hormone receptor (TR) alpha and nuclear expression of its isoform TR\u03b12 determine survival in breast cancer in opposite ways","volume":"15","author":"Schneider","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.1995.1124","article-title":"Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation","volume":"218","author":"Shao","year":"1995","journal-title":"Experimental Cell Research"},{"issue":"8","key":"10.1016\/bs.vh.2024.10.007_bib92","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.clbc.2023.06.009","article-title":"Is the androgen receptor a viable target in triple negative breast cancer in 5 years?","volume":"23","author":"Sharifi","year":"2023","journal-title":"Clinical Breast Cancer"},{"issue":"5","key":"10.1016\/bs.vh.2024.10.007_bib93","first-page":"2793","article-title":"Identification of functional thyroid stimulating hormone receptor and TSHR gene mutations in hepatocellular carcinoma","volume":"38","author":"Shih","year":"2018","journal-title":"Anticancer Research"},{"issue":"15","key":"10.1016\/bs.vh.2024.10.007_bib94","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/onc.2015.262","article-title":"The thyroid hormone-\u03b1v\u03b23 integrin axis in ovarian cancer: Regulation of gene transcription and MAPK-dependent proliferation","volume":"35","author":"Shinderman-Maman","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib95","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"7","key":"10.1016\/bs.vh.2024.10.007_bib96","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1016\/j.bbagen.2012.07.014","article-title":"Thyroid hormone\u2019s action on progenitor\/stem cell biology: New challenge for a classic hormone?","volume":"1830","author":"Sirakov","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.007_bib97","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1398","article-title":"Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone","volume":"8","author":"Sloan","year":"2006","journal-title":"Breast Cancer Research: BCR"},{"issue":"7","key":"10.1016\/bs.vh.2024.10.007_bib98","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/ERC-20-0277","article-title":"Thyroid status regulates the tumor microenvironment delineating breast cancer fate","volume":"28","author":"Sterle","year":"2021","journal-title":"Endocrine-Related Cancer"},{"issue":"10","key":"10.1016\/bs.vh.2024.10.007_bib99","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S1470-2045(14)70379-1","volume":"15","author":"Stupp","year":"2014","journal-title":"The Lancet Oncology"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.007_bib100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-15-0989","article-title":"Hypothyroidism and hyperthyroidism and breast cancer risk: A nationwide cohort study","volume":"174","author":"S\u00f8gaard","year":"2016","journal-title":"European Journal of Endocrinology\/European Federation of Endocrine Societies"},{"issue":"1A","key":"10.1016\/bs.vh.2024.10.007_bib101","first-page":"79","article-title":"The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression","volume":"25","author":"Takayama","year":"2005","journal-title":"Anticancer Research"},{"issue":"2","key":"10.1016\/bs.vh.2024.10.007_bib102","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.hemonc.2019.02.001","article-title":"Prediction of Oncotype Dx recurrence score using clinical parameters: A comparison of available tools and a simple predictor based on grade and progesterone receptor","volume":"12","author":"Thibodeau","year":"2019","journal-title":"Hematology\/Oncology and Stem Cell Therapy"},{"issue":"9","key":"10.1016\/bs.vh.2024.10.007_bib103","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1002\/ijc.27470","article-title":"Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk","volume":"131","author":"Tosovic","year":"2012","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.007_bib104","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2587","article-title":"Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women","volume":"12","author":"Tosovic","year":"2010","journal-title":"Breast Cancer Research: BCR"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.007_bib105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/EJE-12-0564","article-title":"Triiodothyronine levels in relation to mortality from breast cancer and all causes: A population-based prospective cohort study","volume":"168","author":"Tosovic","year":"2013","journal-title":"European Journal of Endocrinology \/ European Federation of Endocrine Societies"},{"key":"10.1016\/bs.vh.2024.10.007_bib106","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/1471-2407-14-536","article-title":"T3 levels in relation to prognostic factors in breast cancer: A population-based prospective cohort study","volume":"14","author":"Tosovic","year":"2014","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/bs.vh.2024.10.007_bib107","first-page":"2362","article-title":"\u03b1v-Integrin isoform expression in primary human tumors and brain metastases","volume":"133","author":"Vogetseder","year":"2013","journal-title":"International Journal of"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/jcm5010011","article-title":"Epithelial-mesenchymal transition (EMT) and regulation of EMT factors by steroid nuclear receptors in breast cancer: A review and in silico investigation","volume":"5","author":"Voutsadakis","year":"2016","journal-title":"Journal of Clinical Medicine"},{"issue":"10","key":"10.1016\/bs.vh.2024.10.007_bib109","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3390\/cancers15102689","article-title":"Comparison of clinical subtypes of breast cancer within the claudin-low molecular cluster reveals distinct phenotypes","volume":"15","author":"Voutsadakis","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/bs.vh.2024.10.007_bib110","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1007\/s11033-020-05780-1","article-title":"Vitamin D receptor (VDR) and metabolizing enzymes CYP27B1 and CYP24A1 in breast cancer","volume":"47","author":"Voutsadakis","year":"2020","journal-title":"Molecular Biology Reports"},{"issue":"3","key":"10.1016\/bs.vh.2024.10.007_bib111","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/jcm11030687","article-title":"The TSH\/thyroid hormones axis and breast cancer","volume":"11","author":"Voutsadakis","year":"2022","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/bs.vh.2024.10.007_bib112","first-page":"1","article-title":"Thyroid hormone enhances estrogen-mediated proliferation and cell cycle regulatory pathways in steroid receptor-positive breast Cancer","author":"Wahdan-Alaswad","year":"2023","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.007_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100648","article-title":"The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer","volume":"7","author":"Waissengrin","year":"2022","journal-title":"ESMO Open"},{"issue":"4","key":"10.1016\/bs.vh.2024.10.007_bib114","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab006","article-title":"Thyrotropin N-glycosylation and glycan composition in severe primary hypothyroidism","volume":"5","author":"Wide","year":"2021","journal-title":"Journal of the Endocrine Society"},{"issue":"1","key":"10.1016\/bs.vh.2024.10.007_bib115","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004049","article-title":"TSH-TSHR axis promotes tumor immune evasion","volume":"10","author":"Wu","year":"2022","journal-title":"The Journal for ImmunoTherapy of Cancer"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.007_bib116","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s12282-020-01148-2","article-title":"Hereditary breast and ovarian cancer (HBOC): Review of its molecular characteristics, screening, treatment, and prognosis","volume":"28","author":"Yoshida","year":"2021","journal-title":"Breast Cancer (Tokyo, Japan)"},{"issue":"6","key":"10.1016\/bs.vh.2024.10.007_bib117","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000493976","article-title":"TRH neurons and thyroid hormone coordinate the hypothalamic response to cold","volume":"7","author":"Zhang","year":"2018","journal-title":"European Thyroid Journal"},{"issue":"12","key":"10.1016\/bs.vh.2024.10.007_bib118","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1007\/s12011-021-02574-9","article-title":"Relationship between selenium in human tissues and breast cancer: A meta-analysis based on case-control studies","volume":"199","author":"Zhu","year":"2021","journal-title":"Biological Trace Element Research"},{"key":"10.1016\/bs.vh.2024.10.007_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111454","article-title":"Effects of thyroxine on apoptosis and proliferation of mammary tumors","volume":"538","author":"Zyla","year":"2021","journal-title":"Molecular and Cellular Endocrinology"}],"container-title":["Vitamins and Hormones","Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672924000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672924000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T16:25:10Z","timestamp":1755015910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672924000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443295485"],"references-count":119,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2024.10.007","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}